HNF4A and malignant colon neoplasm: We found a 50% reduction in the activation of a β-catenin–responsive TCF reporter construct, a canonical readout for Wnt pathway activity in colon cancer cells [28,43,44] with SPT treatment of RKO colon cancer cells (Figure 5B).